How evolving diagnoses and unclear terminology can undermine patient trust—and what clinicians can do about it.

The medical technology company is transitioning leadership to focus on its next phase of growth and commercial traction for its obstructive sleep apnea therapy in the US market.

Sleep is essential to health, but for many women, getting a full night of quality sleep becomes more difficult during menopause. Hormonal changes can disrupt sleep in several ways, making it harder to fall asleep, stay a...

The oral appliance developer aims to advance dental sleep medicine through investigator-initiated research funding and a new real-world clinical case library.

The gold-standard assay for measuring orexin deficiency in cerebrospinal fluid requires a lumbar puncture and radioactive materials. New findings could help advance testing alternatives for people with narcolepsy.

Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.

New research challenges the 90-day CPAP compliance policy.

What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?

The acquisition adds the FDA-cleared, non-pharmacologic Nidra TOMAC therapy to Resmed’s portfolio, expanding its reach into the treatment of restless legs syndrome.

The new rechargeable home sleep test integrates more sensors than the original, including thermistors, an optical module, and a mic.